###begin article-title 0
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Reduced neuronal cell death after experimental brain injury in mice lacking a functional alternative pathway of complement activation
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 818 820 818 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 768 772 <span type="species:ncbi:10090">mice</span>
Neuroprotective strategies for prevention of the neuropathological sequelae of traumatic brain injury (TBI) have largely failed in translation to clinical treatment. Thus, there is a substantial need for further understanding the molecular mechanisms and pathways which lead to secondary neuronal cell death in the injured brain. The intracerebral activation of the complement cascade was shown to mediate inflammation and tissue destruction after TBI. However, the exact pathways of complement activation involved in the induction of posttraumatic neurodegeneration have not yet been assessed. In the present study, we investigated the role of the alternative complement activation pathway in contributing to neuronal cell death, based on a standardized TBI model in mice with targeted deletion of the factor B gene (fB-/-), a "key" component required for activation of the alternative complement pathway.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 37 39 37 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 268 270 268 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 280 282 280 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 289 291 289 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 295 297 295 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 299 301 299 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 306 308 306 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 498 500 498 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 522 524 522 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 716 718 716 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 726 728 726 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
###xml 504 508 <span type="species:ncbi:10090">mice</span>
###xml 732 736 <span type="species:ncbi:10090">mice</span>
After experimental TBI in wild-type (fB+/+) mice, there was a massive time-dependent systemic complement activation, as determined by enhanced C5a serum levels for up to 7 days. In contrast, the extent of systemic complement activation was significantly attenuated in fB-/- mice (P < 0.05,fB-/- vs. fB+/+; t = 4 h, 24 h, and 7 days after TBI). TUNEL histochemistry experiments revealed that posttraumatic neuronal cell death was clearly reduced for up to 7 days in the injured brain hemispheres of fB-/- mice, compared to fB+/+ littermates. Furthermore, a strong upregulation of the anti-apoptotic mediator Bcl-2 and downregulation of the pro-apoptotic Fas receptor was detected in brain homogenates of head-injured fB-/- vs. fB+/+ mice by Western blot analysis.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 185 186 185 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 265 267 265 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 378 379 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b</italic>
###xml 531 533 531 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 555 557 555 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
###xml 537 541 <span type="species:ncbi:10090">mice</span>
The alternative pathway of complement activation appears to play a more crucial role in the pathophysiology of TBI than previously appreciated. This notion is based on the findings of (a) the significant attenuation of overall complement activation in head-injured fB-/- mice, as determined by a reduction of serum C5a concentrations to constitutive levels in normal mice, and (b) by a dramatic reduction of TUNEL-positive neurons in conjunction with an upregulation of Bcl-2 and downregulation of the Fas receptor in head-injured fB-/- mice, compared to fB+/+ littermates. Pharmacological targeting of the alternative complement pathway during the "time-window of opportunity" after TBI may represent a promising new strategy to be pursued in future studies.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 156 157 156 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 257 258 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 259 260 259 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 450 451 450 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 879 881 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1079 1081 1079 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1082 1084 1082 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1246 1248 1246 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1249 1251 1249 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1252 1254 1252 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1379 1381 1379 1381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 738 741 <span type="species:ncbi:37162?0.34174508126603936">MAC</span>
###xml 943 946 <span type="species:ncbi:37162?0.34174508126603936">MAC</span>
###xml 1152 1155 <span type="species:ncbi:37162?0.34174508126603936">MAC</span>
###xml 1197 1202 <span type="species:ncbi:9606">human</span>
###xml 1314 1317 <span type="species:ncbi:37162?0.34174508126603936">MAC</span>
###xml 1321 1326 <span type="species:ncbi:9606">human</span>
The high incidence of adverse outcomes after traumatic brain injury (TBI) has been attributed in large part to secondary mechanisms of neuronal cell death [1,2]. These include the induction of neuronal apoptosis and complement-mediated neuronal cell lysis [3-7]. Recent evidence suggests that the intracerebral activation of the complement cascade influences the fate of neurons by other than just the "classical" neuroinflammation-mediated effects [8-10]. For example, neuronal apoptosis can be induced by complement activation products, e.g. by binding of the anaphylatoxin C5a to its receptor (C5aR/CD88) expressed on neurons [11-15]. In addition, complement-mediated neuronal cell lysis can occur through the membrane attack complex (MAC; C5b-9) following inactivation of the physiological cellular protection mechanisms against homologous complement-mediated cell death [16-20]. Insights from recent experimental studies on intracerebral MAC injection underline the important role of the membrane attack pathway of complement in contributing to secondary neurodegeneration [21,22]. Posttraumatic complement activation and tissue deposition of the MAC were furthermore demonstrated in injured human and rodent brains by immunohistochemistry [18,23-26]. In addition, we have reported elevated levels of soluble MAC in human cerebrospinal fluid (CSF) after severe head injury [27].
###end p 9
###begin p 10
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 752 754 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 755 757 755 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 975 977 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 787 795 <span type="species:ncbi:9606">patients</span>
###xml 965 973 <span type="species:ncbi:9606">patients</span>
Up to date, most studies which investigated the role of complement activation in the injured brain have focused on the effects of the complement cascade at a point where all three activation pathways converge, i.e. at the level of C3 or further downstream in the cascade [26,28-33]. Thus, the role which the individual pathways of complement activation play in the pathophysiology of TBI has not yet been determined. Recent studies established the alternative pathway of complement activation as a "key player" in the pathogenesis of ischemia/reperfusion-mediated inflammatory diseases outside the CNS [34]. For example, complement activation in renal ischemia/reperfusion injury was shown to be mediated almost exclusively by the alternative pathway [34-36]. In clinical studies on TBI patients, we have reported elevated levels of the crucial components required for alternative pathway complement activation, factor B and C3, in the CSF of severely head-injured patients [37].
###end p 10
###begin p 11
###xml 211 215 <span type="species:ncbi:10090">mice</span>
Here, we demonstrate for the first time an important role of the alternative complement pathway in contributing to posttraumatic neuronal cell death, based on a standardized TBI model in factor B gene-deficient mice.
###end p 11
###begin title 12
Results and discussion
###end title 12
###begin title 13
###xml 53 55 53 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Complement activation is attenuated in brain-injured fB-/- mice
###end title 13
###begin p 14
###xml 36 38 36 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 74 76 74 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 162 164 162 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 192 194 192 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 368 369 368 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 198 202 <span type="species:ncbi:10090">mice</span>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
Screening of serum samples from all fB-/- mice and wild-type littermates (fB+/+) used in the present study revealed that factor B was only detectable in serum of fB+/+ animals, but not in the fB-/- mice. These control experiments were performed to ascertain that the knockout mice are completely devoid of factor B in serum. An exemplary Western blot is shown in Fig. 1.
###end p 14
###begin p 15
###xml 265 267 265 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 274 276 274 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 317 318 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 330 331 330 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 398 400 398 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 535 537 535 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 547 549 547 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 556 558 556 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 574 576 574 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 605 606 605 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 618 619 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 676 678 676 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 1193 1195 1193 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1196 1198 1196 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 285 290 <span type="species:ncbi:10090">mouse</span>
###xml 404 408 <span type="species:ncbi:10090">mice</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
###xml 580 584 <span type="species:ncbi:10090">mice</span>
###xml 682 686 <span type="species:ncbi:10090">mice</span>
Experimental closed head injury in wild-type C57BL/6 mice resulted in a systemic activation of the complement cascade, as determined by significantly elevated serum levels of the complement activation product C5a at all time-points assessed from 4 hours to 7 days (P < 0.05 vs. normal mouse serum, unpaired Student's t-test; Fig. 2). In contrast, anaphylatoxin C5a serum levels were not induced in fB-/- mice at all corresponding time-points after head trauma and found to be in a similar range to baseline levels in normal C57BL/6 or fB-/- mice (P < 0.05 vs. brain-injured fB+/+ mice, unpaired Student's t-test; Fig. 2). The data indicate the lack of C5a increase in sera of fB-/- mice. It seems likely that this is due to impaired generation of C5a via the alternative pathway of complement activation, although accelerated metabolic destruction of C5a in the absence of factor B cannot be ruled out. These findings imply that the alternative pathway is the source for complement activation after brain injury, a notion which was previously substantiated for other inflammatory diseases outside the CNS, such as rheumatoid arthritis, autoimmune nephritis, and ischemia/reperfusion injuries [34,38].
###end p 15
###begin p 16
###xml 129 130 129 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 628 630 628 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 711 713 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
###xml 290 298 <span type="species:ncbi:9606">patients</span>
###xml 441 446 <span type="species:ncbi:9606">human</span>
###xml 454 462 <span type="species:ncbi:9606">patients</span>
###xml 535 543 <span type="species:ncbi:9606">patients</span>
###xml 643 649 <span type="species:ncbi:9606">humans</span>
###xml 777 781 <span type="species:ncbi:10090">mice</span>
###xml 903 908 <span type="species:ncbi:10090">mouse</span>
###xml 938 943 <span type="species:ncbi:9606">human</span>
Experimental head injury induced mean anaphylatoxin C5a levels in serum of around 50 ng/ml within 7 days in wild-type mice (Fig. 2). Serum C5a levels described in the literature due to triggers for complement activation other than CNS trauma are in the range of 100 ng/ml, as described for patients with severe sepsis [39]. With regard to central nervous system inflammation, we have previously reported significantly elevated C5a levels in human CSF of patients with bacterial meningitis (mean levels around 75 ng/ml), as compared to patients with aseptic/viral meningitis [40]. C5a levels were not detectable in normal CSF of n = 66 healthy humans with a lower limit of sensitivity of the assay at 1.5 ng/ml [40]. Thus, the serum C5a levels detected in brain-injured C57BL/6 mice in the present study appear to reflect concentrations of clinical relevance, as far as data derived from an experimental mouse model can be extrapolated to human disease.
###end p 16
###begin title 17
The lack of factor B leads to reduced neuronal cell death after head injury
###end title 17
###begin p 18
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 165 167 165 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 175 177 175 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 416 418 416 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 496 497 496 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 497 501 497 501 <bold xmlns:xlink="http://www.w3.org/1999/xlink">and </bold>
###xml 506 507 506 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 509 521 509 521 <bold xmlns:xlink="http://www.w3.org/1999/xlink">panels D &amp; E</bold>
###xml 531 533 531 533 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E </bold>
###xml 570 571 570 571 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 636 643 636 643 <bold xmlns:xlink="http://www.w3.org/1999/xlink">panel C</bold>
###xml 895 896 895 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 898 911 898 911 <bold xmlns:xlink="http://www.w3.org/1999/xlink">panels A &amp; B </bold>
###xml 919 921 919 921 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B </bold>
###xml 958 959 958 959 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 1214 1215 1214 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1459 1460 1459 1460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1489 1490 1489 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1490 1494 1490 1494 <bold xmlns:xlink="http://www.w3.org/1999/xlink">and </bold>
###xml 1494 1495 1494 1495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1615 1617 1615 1617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 1625 1627 1625 1627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 1818 1820 1818 1820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1821 1823 1821 1823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1892 1894 1892 1894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 1908 1910 1908 1910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 2033 2034 2033 2034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 2034 2038 2034 2038 <bold xmlns:xlink="http://www.w3.org/1999/xlink">and </bold>
###xml 2043 2044 2043 2044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 2046 2059 2046 2059 <bold xmlns:xlink="http://www.w3.org/1999/xlink">panels I &amp; J </bold>
###xml 2059 2061 2059 2061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 2063 2068 2063 2068 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D &amp; E</bold>
###xml 2188 2189 2188 2189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 2245 2247 2245 2247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 2262 2263 2262 2263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 2635 2636 2635 2636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 2637 2639 2637 2639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 2640 2642 2640 2642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 2643 2645 2643 2645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 2663 2671 2663 2671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 2992 2994 2992 2994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 3120 3122 3120 3122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
###xml 422 426 <span type="species:ncbi:10090">mice</span>
###xml 1595 1599 <span type="species:ncbi:10090">mice</span>
###xml 1808 1816 <span type="species:ncbi:9606">patients</span>
###xml 1898 1902 <span type="species:ncbi:10090">mice</span>
###xml 2165 2169 <span type="species:ncbi:10090">mice</span>
###xml 2251 2255 <span type="species:ncbi:10090">mice</span>
###xml 2498 2502 <span type="species:ncbi:10090">mice</span>
###xml 2998 3002 <span type="species:ncbi:10090">mice</span>
The mortality from brain injury in this model system is approximately 5-8% within 7 days, as previously reported [41]). There was no difference in mortality between fB-/- and fB+/+ mice. As previously described, neuronal cell death was observed in injured brains of wild-type C57BL/6 mice for up to 7 days after closed head injury [41]. An increase in TUNEL-positive cells was detected in the injured hemispheres of fB+/+ mice within 4 to 24 hours after trauma, persisting for up to 7 days (Fig. 3and Fig. 4; panels D & E; whereby E represents a 4-fold magnification of D). The nuclear staining with 4',6'-diamino-2-phenylindole (DAPI; panel C) shows the cellular morphology in adjacent sections to those assessed by TUNEL histochemistry. Neurons were determined as the main TUNEL-positive cell-type by immunohistochemical staining of adjacents sections with the specific cell-marker NeuN (Fig. 4, panels A & B whereby B represents a 4-fold magnification of A). The staining of astrocytes (anti-GFAP), microglia (anti-CD11b), and endothelial cells (anti-CD144) revealed that these resident cells in the brain are represent only a small part of TUNEL-positive cells, e.g. in the molecular layer of the cortex (Fig. 4). Furthermore, neurons were confirmed as the predominant TUNEL-positive cell-type by their typical cellular size and morphology (as opposed to glial cells) and to the typical neuronal layers of TUNEL-positive cells in the injured cortex (Fig. 4). The data shown in figures 3and 4 are highly reproducible in all tissue sections and animals assessed and are representative for 2-3 mice of each group (fB+/+ and fB-/-) per time-point assessed. These findings corroborate previously published data on neuronal apoptosis in the current and other experimental TBI models as well as in head-injured patients [41-45]. In contrast to the extent of neuronal cell death in brain-injured fB+/+ mice, the fB-/- animals showed a clear reduction in TUNEL-positive neurons in injured brains from 4 hours to 7 days after trauma (Fig. 3and Fig. 4, panels I & J vs. D & E, respectively). In addition, the evident cortical tissue destruction in brain-injured wild-type mice at 24 hours (Fig. 3, upper panels) appears to be structurally preserved in fB-/- mice (Fig. 3, bottom panels). TUNEL-positive cells and extent of tissue destruction were less in the contralateral (right) hemisphere as compared to the injured (left) hemisphere at all time-points assessed, both in the knockout and the wild-type mice (data not shown). These findings support the recently established concept of complement-dependent regulation of neuronal apoptosis [7,10,15,46] and promote the in vivo significance of the alternative (factor B-dependent) pathway of complement activation in regulating the extent of secondary neurodegeneration after TBI. This is the first study, to our knowledge, which investigated exclusively the role of the alternative pathway in contributing to neuropathology after brain injury. The fB-/- mice have previously been shown to be protected from experimental demyelination in an animal model of multiple sclerosis [47]. The studies by Nataf and colleagues support our present findings in that the genetic deficiency of factor B, which provokes the complete lack of a functional alternative complement activation pathway, plays an essential role for neuroprotection in models of autoimmune and traumatic CNS injury.
###end p 18
###begin title 19
###xml 59 61 59 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
Upregulation of Bcl-2 and downregulation of Fas in injured fB-/- brains
###end title 19
###begin p 20
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 367 369 367 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 453 455 453 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 477 478 477 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 584 585 584 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 703 705 703 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 732 733 732 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 973 975 973 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1223 1225 1223 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 373 377 <span type="species:ncbi:10090">mice</span>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
###xml 709 713 <span type="species:ncbi:10090">mice</span>
###xml 967 971 <span type="species:ncbi:10090">mice</span>
###xml 1092 1096 <span type="species:ncbi:10090">mice</span>
###xml 1124 1128 <span type="species:ncbi:10090">mice</span>
###xml 1229 1233 <span type="species:ncbi:10090">mice</span>
Posttraumatic neuronal apoptosis has been shown to be promoted by the Fas-mediated extrinsic pathway and by a suppression of the mitochondrial anti-apoptotic mediator Bcl-2 of the intrinsic pathway of apoptosis [48-54]. By Western blot analysis, we found a marked upregulation of protective Bcl-2 protein levels in brain homogenates of sham-operated and head-injured fB-/- mice at 24 hours - and to a lesser degree at 7 days - after trauma, compared to fB+/+ littermates (Fig. 5). No differences in Bcl-2 expression between knockout and wild-type mice was seen at 4 h after TBI (Fig. 5). Interestingly, sham-operation alone was a sufficient trigger for inducing Bcl-2 protein expression in the brain of fB-/- mice within 24 h (Fig. 5). We have previously reported the phenomenon of increased intracerebral mediator expression by sham operation alone (i.e. anesthesia and scalp incision) such as for the anaphylatoxin C5a receptor (C5aR/CD88) in sham-operated C57BL/6 mice [13]. In the present study, it appears that the threshold for induction of Bcl-2 in the brain of sham-operated knockout mice is lower than in wild-type mice, thus possibly contributing to increased intracerebral Bcl-2 levels also in the brain-injured fB-/- mice. We plan to explore the pharmacological aspects of this phenomenon in future studies.
###end p 20
###begin p 21
###xml 149 151 149 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 173 175 173 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 466 467 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 864 866 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 867 869 867 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 1133 1135 1133 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 1266 1267 1266 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1268 1270 1268 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 1271 1273 1271 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 1274 1276 1274 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
###xml 1019 1034 <span type="species:ncbi:10090">transgenic mice</span>
With regard to the extrinsic pathway of apoptosis, a marked downregulation in Fas receptor expression was seen within 4 hours to 7 days after TBI in fB-/- mice, compared to fB+/+ animals (Fig. 5). Although these data are not quantitative, the differences in staining intensity of the 26 kDa (Bcl-2) and 48 kDa bands (Fas) appear more intense in the brain-injured knockout mice than in the corresponding wild-type littermates at the above-mentioned time-points (Fig. 5). These findings suggest, but do not prove, an involvement of the alternative pathway of complement activation in regulating neuronal apoptosis after TBI by suppression of Bcl-2 and induction of Fas receptor expression in the injured brain. Both aspects are critical in the regulation of post-injury neuronal apoptosis, as previously determined by other investigators in different model systems [48-50]. An experimental study on a controlled cortical impact brain injury model demonstrated that the cortical lesion volume was significantly reduced in transgenic mice with over-expression of the Bcl-2 gene by 7 days after trauma, compared to wild-type littermates [55]. Thus, Bcl-2 was attributed an important role in the regulation of the mitochondrial (intrinsic) pathway of apoptosis after TBI [4,53,55,56].
###end p 21
###begin p 22
###xml 128 135 128 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crry-Ig</italic>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 455 463 455 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crry-Ig </italic>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 139 145 <span type="species:ncbi:10090">murine</span>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 378 384 <span type="species:ncbi:10090">murine</span>
We have recently shown that the pharmacological "pan"-inhibition of complement activation at the level of the C3 convertases by Crry-Ig, a murine recombinant chimeric fusion molecule, leads to enhanced intracerebral Bcl-2 gene and protein expression and to increased neuronal survival in the hippocampus of brain-injured mice [32]. Similar findings were described in a model of murine autoimmune cerebritis, where the blocking of complement activation by Crry-Ig resulted in a significant attenuation of neuronal apoptosis [15].
###end p 22
###begin p 23
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
The data from the present study support the biological significance of the alternative pathway of complement activation in contributing to the neuropathological sequelae of TBI and provide the basis for future pharmacological studies with selective alternative pathway inhibitors, e.g. such as factor B antagonists [34,57].
###end p 23
###begin title 24
Conclusion
###end title 24
###begin p 25
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 549 551 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 655 657 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 923 925 923 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 926 928 926 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 1040 1048 1040 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1185 1187 1185 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 1307 1309 1307 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1297 1305 <span type="species:ncbi:9606">patients</span>
In summary, the present data provide first evidence of a major role of the alternative pathway of complement activation in contributing to the overall extent of posttraumatic complement activation (C5a generation) and to secondary neuronal cell death after brain injury (TUNEL, Bcl-2, and Fas data). This is a fairly new and provocative notion, since all previously published studies on experimental complement inhibition in TBI models have focussed on interfering with the complement cascade at the "common junction" level of C3 convertases [26,28-32] or further downstream in the cascade, e.g. by specific blocking of anaphylatoxin C5a or its receptor [30]. The hitherto underestimation of the pathophysiological role of the alternative complement pathway in the neuropathology of brain injury may be in part due to the historically established predominant role of the classical pathway in various neurological diseases [58,59]. However, the results from the present study imply that these insights may not necessarily reflect the "true" in vivo significance of the alternative complement pathway in a complex multifactorial neuroinflammatory disease, such as in the setting of TBI [60]. The fact that elevated factor B levels are present in the intrathecal compartment of severely head-injured patients [37] further supports the concept that the pharmacological targeting of factor B may present a reasonable basis for future investigations.
###end p 25
###begin title 26
Methods
###end title 26
###begin title 27
###xml 12 16 <span type="species:ncbi:10090">mice</span>
Factor B-/- mice
###end title 27
###begin p 28
###xml 49 51 49 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 502 504 502 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 848 858 842 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ad libitum</italic>
###xml 1094 1096 1088 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 1097 1099 1091 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 1173 1234 1167 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Federation of European Laboratory Animal Science Association </italic>
###xml 1304 1376 1298 1370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Landesamt f&#252;r Arbeitsschutz, Gesundheitsschutz und technische Sicherheit</italic>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 470 474 <span type="species:ncbi:10090">mice</span>
###xml 870 874 <span type="species:ncbi:10090">mice</span>
The genetic knockout mice deficient in factor B (fB-/-) were previously characterized and shown to have a complete lack of a functional alternative complement pathway [61]. They were originally created with Sv129 embryonic stem cells and crossed with C57BL/6 mice prior to expansion of the colony at F1. They were then back-crossed for more than 10 generations against a pure C57BL/6 background and found to be grossly indistinguishable from C57BL/6 mice [35]. Knockout mice and wild-type littermates (fB+/+) were acclimatized several weeks before the experiments and kept isolated from external influences during the entire time course of the study. They were bred in a selective pathogen-free (SPF) environment and standardized conditions of temperature (21degreesC), humidity (60%), light and dark cycles (12:12 h), with food and water provided ad libitum. Only male mice were used for this study in order to avoid a bias in gender with regard to levels of complement activity and to susceptibility to brain injury which seems to be significantly influenced by female reproductive hormones [62,63]. All experiments were performed in compliance with the standards of the Federation of European Laboratory Animal Science Association (FELASA) and were approved by the institutional animal care commitee (Landesamt fur Arbeitsschutz, Gesundheitsschutz und technische Sicherheit, Berlin, Germany, No. G0099/03 and No. G0308/04).
###end p 28
###begin title 29
Brain injury model
###end title 29
###begin p 30
###xml 59 61 59 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 98 100 98 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 128 130 128 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 549 551 549 551 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 636 638 636 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 501 505 <span type="species:ncbi:10090">mice</span>
###xml 664 668 <span type="species:ncbi:10090">mice</span>
Experimental closed head injury was performed in knockout (fB-/-) mice and wild-type littermates (fB+/+) of the C57BL/6 strain (n = 6 per group and time-point) using a standardized weight-drop device, as previously described [13,41,64-66]. In brief, after induction of isoflurane anesthesia, the skull was exposed by a midline longitudinal scalp incision. A 333 g weight was dropped on the fixed skull from a height of 2 cm, resulting in a focal blunt injury to the left hemisphere. After trauma, the mice received supporting oxygenation with 100% O2 until fully awake and were then brought back to their cages. At defined time-points (t = 4 h, 24 h, and 7 days), mice were euthanized and brain hemispheres were extracted for analysis by immunohistochemistry, TUNEL histochemistry, and SDS-PAGE/Western blot analysis. In addition, serum samples were collected for determination of complement anaphylatoxin C5a levels by ELISA and Western blot analysis of Bcl-2 (see below).
###end p 30
###begin p 31
###xml 14 18 <span type="species:ncbi:10090">mice</span>
Sham-operated mice were kept under identical conditions as the trauma group and underwent the same procedures (anesthesia and scalp incision) except that no head injury was applied.
###end p 31
###begin title 32
###xml 10 15 <span type="species:ncbi:10090">mouse</span>
ELISA for mouse C5a
###end title 32
###begin p 33
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 354 359 <span type="species:ncbi:10090">mouse</span>
###xml 802 808 <span type="species:ncbi:10090">murine</span>
###xml 821 826 <span type="species:ncbi:10090">mouse</span>
###xml 970 975 <span type="species:ncbi:10090">mouse</span>
For determination of complement anaphylatoxin C5a levels in serum samples of head-injured and normal C57BL/6 control mice, we used an ELISA developed in the laboratory of Dr. P.A. Ward (Ann Arbor, MI, USA), as previously described [67]. In brief, ELISA plates (Immulon 4HBX, Thermo Labsystems, Milford, MA, USA) were coated with purified monoclonal anti-mouse C5a IgG (5 mug/ml, BD Pharmingen, San Diego, CA, USA). This capture antibody recognizes both C5a and C5a-desArg, but not the precursor molecule C5. After blocking of non-specific binding sites with 1% milk (Roth, Karlsruhe, Germany) in PBS (Gibco-Invitrogen, Carlsbad, CA, USA) containing 0.05% TWEEN 20 (Sigma-Aldrich, St. Louis, MO, USA), the plate was coated with 100 mul serum diluted 1:20 (in 0.1% milk in PBS contaning 0.05% TWEEN) and murine recombinant mouse C5a at defined concentrations for establishing the standard curve. After incubation and subsequent washing steps, biotinylated monoclonal anti-mouse C5a antibody was added at 500 ng/ml (BD Pharmingen) followed by washing steps and incubation with streptavidin-peroxidase at 400 ng/ml (Sigma). For colorimetric reaction, the substrate (0.4 mg/ml OPD with 0,4 mg/ml urea hydrogen peroxide in 0.05 M phosphate citrate buffer; Sigma) was added and the color reaction was stopped with 3 M sulfuric acid. The absorbance was read at 490 nm ("SpectraMax 190" reader, Molecular Devices, Sunnyvale, CA, USA. All samples were analyzed in duplicate wells and results were calculated from the means of duplicate sample analysis. The standard curve was linear from 50 ng/ml to 0.1 ng/ml which represents the lower limit of detection of this assay.
###end p 33
###begin title 34
Western blot
###end title 34
###begin p 35
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 388 390 388 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 398 400 398 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 874 878 871 873 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 2419 2423 2410 2412 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 4 8 <span type="species:ncbi:10090">mice</span>
###xml 286 291 <span type="species:ncbi:10090">mouse</span>
###xml 404 408 <span type="species:ncbi:10090">mice</span>
###xml 477 482 <span type="species:ncbi:10090">mouse</span>
###xml 1674 1679 <span type="species:ncbi:10090">mouse</span>
###xml 1761 1767 <span type="species:ncbi:9986">rabbit</span>
###xml 1773 1778 <span type="species:ncbi:10090">mouse</span>
###xml 1835 1842 <span type="species:ncbi:9031">chicken</span>
###xml 1848 1853 <span type="species:ncbi:10090">mouse</span>
All mice used in this study were screened by Western blot analysis for the presence of factor B in serum, as an internal quality control (Fig. 1). The protein levels of the mitochondrial anti-apoptotic mediator Bcl-2 and of the pro-apoptotic Fas receptor were determined in homogenized mouse brains and matched serum samples at 4 h, 24 h and 7d following head injury or sham operation in fB-/- and fB+/+ mice. The Western blot technique was previously described [32]. Briefly, mouse brains were extracted under anesthesia, separated into left and right hemispheres, and immediately homogenized in lysis buffer (Sigma) containing 100 mM TRIS-HCl (pH 7.5), 150 mM NaCl, 0.5% sodium dodecyl sulfate (SDS), 0.5% Nonidet P-40, 10 mug/ml aprotinin, 10 mug/ml leupeptin, 5 mug/ml pepstatin, 1 mM phenyl-methyl-sulfonyl fluoride in deionized water, using an Ultra Turrax Homogenizer(R) (IKA Werke, Staufen, Germany). After 15 min centrifugation at 13,000 x g, the protein content of the supernatants was determined by commercially available colorimetric protein assay ("BCA Protein Assay", Pierce/Perbio Science, Bonn, Germany). A 60 mug sample of total protein was denatured in loading buffer and separated under reducing conditions on 12% SDS-polyacrylamide gels in parallel with a broad range prestained SDS-PAGE protein standard (Bio-Rad, Munich, Germany). Proteins were then transferred to Protran BA 83 nitrocellulose membranes (Schleicher & Schuell, Dassel, Germany) by electroblotting (Bio-Rad). Equal transfer of protein to the blotting membrane was confirmed by ponceau red staining (Sigma). The blots were blocked overnight and then incubated with either monoclonal anti-mouse Bcl-2 (Santa Cruz Biotechnology, Heidelberg, Germany), diluted 1:500, polyclonal rabbit anti-mouse Fas (clone A-20, Santa Cruz), diluted 1:200, polyclonal chicken anti-mouse anti-factor B, diluted 1:8,000 (kindly provided by Dr. Scott R. Barnum, University of Alabama at Birmingham, AL, USA) as primary antibodies, and with a monocloncal anti-beta-actin antibody (clone AC-15, Sigma) diluted 1:10,000, as internal control for ascertaining equal loading of the bands. After incubation with peroxidase-labelled secondary antibodies (Dako, Hamburg, Germany, and Santa Cruz Biotechnology, Heidelberg, Germany), diluted 1:5,000, antibody binding was visualized by a non-radioactive chemiluminescence technique using a commercially available ECL(R) Western blotting kit (Amersham Pharmacia Biotech, Freiburg, Germany). A semi-quantitative analysis of the individual band intensities was performed by scanning the films (hp Scanjet 5530, Hewlett-Packard, Boblingen, Germany) followed by quantification using the TINA 2.09 software (Raytest, Straubenhardt, Germany). The data are presented in histograms as relative levels to the according beta-actin band intensity.
###end p 35
###begin title 36
Immunohistochemistry
###end title 36
###begin p 37
###xml 541 543 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 544 546 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
###xml 715 721 <span type="species:ncbi:9986">rabbit</span>
###xml 805 808 <span type="species:ncbi:10116">rat</span>
###xml 893 897 <span type="species:ncbi:9925">goat</span>
For assessment of neuronal morphology, integrity, and apoptosis, extracted mouse brains were snap-frozen in liquid nitrogen, embedded in OCT compound (Sakura Finetek, Torrance, CA) and stored at -80degreesC until used for analysis. Six to eight-micrometer thick coronal tissue sections were cut with a cryostat at -20degreesC. For immunohistochemistry, slides were fixed in acetone and then analyzed by a standard biotin/avidin/peroxidase technique with DAB-tetrahydrochloride as chromogen (Vector, Burlingame, CA), as previously described [13,32]. The following primary antibodies were used as cell-markers: monoclonal anti-NeuN, at a titrated dilution of 1:2,000 (Chemicon, Hampshire, UK) for neurons; polyclonal rabbit anti-GFAP, 1:100 (Shandon Immunon, Pittsburgh, PA, USA) for astrocytes; monoclonal rat anti-CD11b, 1:100, (Accurate Chemical, Westbury, NY, USA) for microglia; polyclonal goat-anti CD144, 1:200 (Santa Cruz) for endothelial cells. Non-immunized IgG (Vector) was used as negative control at equal dilutions as the omitted specific antibody.
###end p 37
###begin p 38
###xml 118 126 118 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In Situ </italic>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1168 1172 1156 1158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
To determine the extent of intracerebral neuronal cell death, TUNEL histochemistry was performed using a "Fluorescein In Situ Cell Death Detection Kit" (Roche Diagnostics GmbH, Mannheim, Germany), according to the manufacturer's instructions, as previously described [41]. Briefly, slides were dried for 30 min followed by fixation in 10% formalin solution at RT. After washing in PBS (three times for 3 min), sections were incubated in ice-cold ethanol-acetic acid solution (2:1) for 5 min at -20degreesC. Thereafter, they were washed in PBS and incubated in a permeabilization solution with 3% Triton X-100 in PBS for 60 min at RT, then incubated with the TdT enzyme in a reaction buffer containing fluorescein-dUTP for 90 min at 37degreesC. Negative control was performed using only the reaction buffer without TdT enzyme. Positive controls were performed by digesting equal brain sections with DNase grade I solution (500 U/ml; Roche) for 20 min at RT and always kept separate from the other samples thereafter. After labelling, the sections were washed again in PBS and to visualize the unstained (TUNEL-negative) cells, the sections were covered with Vectashield(R) mounting medium for fluorescence with DAPI (Vector). All samples were evaluated immediately after staining using an Axioskop 40 fluorescence microscope (Zeiss, Germany) at 460 nm for DAPI and 520 nm for TUNEL fluorescence and analyzed by Alpha digi doc 1201 software (Alpha Innotech, San Leandro, CA, USA).
###end p 38
###begin title 39
Statistical analysis
###end title 39
###begin p 40
###xml 156 158 147 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 166 168 157 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 219 220 210 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 229 230 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
Statistical analysis was performed using commercially available software (SPSS 9.0 for Windowstrade mark). Differences in complement C5a levels in serum of fB-/- and fB+/+ mice were determined by the unpaired Student's t-test. A P-value < 0.05 was considered statistically significant.
###end p 40
###begin title 41
Abbreviations
###end title 41
###begin p 42
###xml 166 173 166 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crry-Ig</italic>
###xml 310 312 310 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 344 346 344 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 156 161 <span type="species:ncbi:10090">mouse</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 417 420 <span type="species:ncbi:37162?0.34174508126603936">MAC</span>
C5a receptor (C5aR, CD88); central nervous system (CNS); cerebrospinal fluid (CSF); complement receptor type 1-related protein y chimeric molecule fused to mouse Ig (Crry-Ig); diaminobenzidine (DAB); 4',6'-diamino-2-phenylindole (DAPI); enyzme-linked immunosorbent assay (ELISA); factor B gene-deficient mice (fB-/-) and wild-type littermates (fB+/+); glial fibrillary acidic protein (GFAP); membrane attack complex (MAC, C5b-9); neuron-specific nuclear protein (NeuN); o-phenylenediamine dihydrochloride (OPD); phosphate-buffered saline (PBS); room temperature (RT); sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE); traumatic brain injury (TBI); terminal deoxynucleotidyl transferase (TdT); terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling (TUNEL).
###end p 42
###begin title 43
Competing interests
###end title 43
###begin p 44
The author(s) declare that they have no competing interests.
###end p 44
###begin title 45
Authors' contributions
###end title 45
###begin p 46
###xml 215 219 <span type="species:ncbi:10090">mice</span>
###xml 472 478 <span type="species:ncbi:10090">murine</span>
IL, OIS, and PFS were responsible for conception and planning of the experiments, performing of all animal experiments, analysis of the data and writing of the manuscript. VMH and JMT provided the factor B knockout mice and wild-type littermates and assisted in the conception of the experiments and analysis of the data. IL and DH performed the TUNEL and immunohistochemistry experiments. MP and MET performed the Western blot experiments. DR, MHL, and PAW performed the murine C5a ELISA experiments and assisted in the interpretation of the results. WRS assisted in analysis of the data and writing of the manuscript.
###end p 46
###begin title 47
Acknowledgements
###end title 47
###begin p 48
###xml 170 175 <span type="species:ncbi:10090">mouse</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
We thank Mrs. Claudia Conrad for excellent technical assistance. Dr. Scott R. Barnum (University of Alabama at Birmingham AL, USA) is acknowledged for providing the anti-mouse factor B antibodies used for screening of the knockout and wild-type mice. This study was supported by grants No. STA 635/1-1, STA 635/1-2, STA 635/2-1, and STA 635/2-2 from the German Research Foundation (DFG) to PFS and OIS; NIH grants R01 AI31105 to VMH and K08 DK64790 to JMT; grants GM 61656 and GM 029507 to PAW. The continuing inspiration of EAP is acknowledged.
###end p 48
###begin article-title 49
Moderate and severe traumatic brain injury: epidemiologic, imaging and neuropathologic perspectives
###end article-title 49
###begin article-title 50
The neurophysiology of brain injury
###end article-title 50
###begin article-title 51
Caspase pathways, neuronal apoptosis, and CNS injury
###end article-title 51
###begin article-title 52
Cell death mechanisms following traumatic brain injury
###end article-title 52
###begin article-title 53
Apoptosis and traumatic brain injury
###end article-title 53
###begin article-title 54
Bench-to-bedside review: Apoptosis/programmed cell death triggered by traumatic brain injury
###end article-title 54
###begin article-title 55
The role of the complement system in traumatic brain injury
###end article-title 55
###begin article-title 56
Beyond lysis: how complement influences cell fate
###end article-title 56
###begin article-title 57
The role of neuroinflammation in traumatic brain injury
###end article-title 57
###begin article-title 58
Complement regulator loss on apoptotic neuronal cells causes increased complement activation and promotes both phagocytosis and cell lysis
###end article-title 58
###begin article-title 59
A neuronal C5a receptor and an associated apoptotic signal transduction pathway
###end article-title 59
###begin article-title 60
Complement anaphylatoxin receptors on neurons: new tricks for old receptors?
###end article-title 60
###begin article-title 61
###xml 130 134 <span type="species:ncbi:10090">mice</span>
Intracerebral complement C5a receptor (CD88) expression is regulated by TNF and lymphotoxin-alpha following closed head injury in mice
###end article-title 61
###begin article-title 62
Neuronal expression of a functional receptor for the C5a complement activation fragment
###end article-title 62
###begin article-title 63
###xml 64 70 <span type="species:ncbi:10090">murine</span>
Complement-dependent apoptosis and inflammatory gene changes in murine lupus cerebritis
###end article-title 63
###begin article-title 64
Regulation of the complement membrane attack pathway
###end article-title 64
###begin article-title 65
###xml 86 91 <span type="species:ncbi:9606">human</span>
Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis
###end article-title 65
###begin article-title 66
###xml 29 34 <span type="species:ncbi:9606">human</span>
Complement activation in the human brain after traumatic head injury
###end article-title 66
###begin article-title 67
###xml 63 66 <span type="species:ncbi:10116">rat</span>
Complement activation following optic nerve crush in the adult rat
###end article-title 67
###begin article-title 68
Complement activation after lumbosacral ventral root avulsion injury
###end article-title 68
###begin article-title 69
###xml 101 104 <span type="species:ncbi:10116">rat</span>
Intracerebroventricular injection of terminal complement complex causes inflammatory reaction in the rat brain
###end article-title 69
###begin article-title 70
Formation of complement membrane attack complex in Mammalian cerebral cortex evokes seizures and neurodegeneration
###end article-title 70
###begin article-title 71
###xml 120 123 <span type="species:ncbi:10116">rat</span>
Activation of the complement cascade and increase of clusterin in the brain following a cortical contusion in the adult rat
###end article-title 71
###begin article-title 72
###xml 75 79 <span type="species:ncbi:10116">rats</span>
Local neutrophil influx following lateral fluid-percussion brain injury in rats is associated with accumulation of complement activation fragments of the third component (C3) of the complement system
###end article-title 72
###begin article-title 73
###xml 109 113 <span type="species:ncbi:10116">rats</span>
Enhanced glial activation and expression of specific CNS inflammation-related molecules in aged versus young rats following cortical stab injury
###end article-title 73
###begin article-title 74
###xml 107 122 <span type="species:ncbi:10090">transgenic mice</span>
Central nervous system-targeted complement inhibition mediates neuroprotection after closed head injury in transgenic mice
###end article-title 74
###begin article-title 75
###xml 132 140 <span type="species:ncbi:9606">patients</span>
Intrathecal levels of complement-derived soluble membrane attack complex (sC5b-9) correlate with blood-brain barrier dysfunction in patients with traumatic brain injury
###end article-title 75
###begin article-title 76
###xml 99 103 <span type="species:ncbi:10116">rats</span>
Effect of soluble complement receptor-1 on neutrophil accumulation after traumatic brain injury in rats
###end article-title 76
###begin article-title 77
###xml 0 14 <span type="species:ncbi:10245">Vaccinia virus</span>
Vaccinia virus complement control protein enhances functional recovery after traumatic brain injury
###end article-title 77
###begin article-title 78
Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5a receptor antagonist
###end article-title 78
###begin article-title 79
###xml 18 32 <span type="species:ncbi:10245">Vaccinia virus</span>
Administration of Vaccinia virus complement control protein shows significant cognitive improvement in a mild injury model
###end article-title 79
###begin article-title 80
Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury
###end article-title 80
###begin article-title 81
The role of the complement system in CNS inflammatory diseases
###end article-title 81
###begin article-title 82
The alternative pathway of complement in disease: opportunities for therapeutic targeting
###end article-title 82
###begin article-title 83
###xml 96 100 <span type="species:ncbi:10090">mice</span>
Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice
###end article-title 83
###begin article-title 84
Acute tubular necrosis is characterized by activation of the alternative pathway of complement
###end article-title 84
###begin article-title 85
###xml 99 107 <span type="species:ncbi:9606">patients</span>
Elevated levels of the complement components C3 and factor B in ventricular cerebrospinal fluid of patients with traumatic brain injury
###end article-title 85
###begin article-title 86
###xml 58 63 <span type="species:ncbi:9606">human</span>
The central role of the alternative complement pathway in human disease
###end article-title 86
###begin article-title 87
Neutrophil dysfunction in sepsis - Evidence for the role of complement activation products in cellular deactivation
###end article-title 87
###begin article-title 88
TNF-alpha-mediated expression of the receptor for anaphylatoxin C5a on neurons in experimental Listeria meningoencephalitis
###end article-title 88
###begin article-title 89
###xml 165 169 <span type="species:ncbi:10090">mice</span>
Experimental closed head injury: analysis of neurological outcome, blood-brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines
###end article-title 89
###begin article-title 90
###xml 82 85 <span type="species:ncbi:10116">rat</span>
Evidence of apoptosic cell death after experimental traumatic brain injury in the rat
###end article-title 90
###begin article-title 91
Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury
###end article-title 91
###begin article-title 92
###xml 86 89 <span type="species:ncbi:9606">man</span>
In situ DNA fragmentation occurs in white matter up to 12 months after head injury in man
###end article-title 92
###begin article-title 93
Neuron-specific mRNA complexity responses during hippocampal apoptosis after traumatic brain injury
###end article-title 93
###begin article-title 94
CD46 plays a key role in tailoring innate immune recognition of apoptotic and necrotic cells
###end article-title 94
###begin article-title 95
###xml 77 81 <span type="species:ncbi:10090">mice</span>
Attenuation of experimental autoimmune demyelination in complement-deficient mice
###end article-title 95
###begin article-title 96
Pathways leading to apoptotic neurodegeneration following trauma to the developing brain
###end article-title 96
###begin article-title 97
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 107 113 <span type="species:ncbi:9606">humans</span>
Upregulation of the Fas receptor death-inducing signaling complex after traumatic brain injury in mice and humans
###end article-title 97
###begin article-title 98
Mild traumatic brain injury induces apoptotic cell death in the cortex that is preceded by decreases in cellular Bcl-2 immunoreactivity
###end article-title 98
###begin article-title 99
###xml 89 92 <span type="species:ncbi:10116">rat</span>
Temporal alterations in cellular Bax:Bcl-2 ratio following traumatic brain injury in the rat
###end article-title 99
###begin article-title 100
Common patterns of bcl-2 family gene expression in two traumatic brain injury models
###end article-title 100
###begin article-title 101
Mitochondrial apoptotic pathways
###end article-title 101
###begin article-title 102
Apoptosis and caspases in neurodegenerative diseases
###end article-title 102
###begin article-title 103
###xml 83 98 <span type="species:ncbi:10090">transgenic mice</span>
Bcl-2 overexpression attenuates cortical cell loss after traumatic brain injury in transgenic mice
###end article-title 103
###begin article-title 104
Regulation of neuronal cell death and neurodegenerationby members of the Bcl-2 family: therapeutic implications
###end article-title 104
###begin article-title 105
###xml 117 121 <span type="species:ncbi:10090">mice</span>
A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice
###end article-title 105
###begin article-title 106
Expression of complement in the brain: role in health and disease
###end article-title 106
###begin article-title 107
Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease
###end article-title 107
###begin article-title 108
Closed head injury - an inflammatory disease?
###end article-title 108
###begin article-title 109
###xml 73 79 <span type="species:ncbi:10090">murine</span>
Abrogation of the alternative complement pathway by targeted deletion of murine factor B
###end article-title 109
###begin article-title 110
Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone
###end article-title 110
###begin article-title 111
###xml 133 137 <span type="species:ncbi:10116">rats</span>
Progesterone differentially regulates pro- and anti-apoptotic gene expression in cerebral cortex following traumatic brain injury in rats
###end article-title 111
###begin article-title 112
###xml 47 51 <span type="species:ncbi:10090">mice</span>
An experimental model of closed head injury in mice: pathophysiology, histopathology, and cognitive deficits
###end article-title 112
###begin article-title 113
###xml 31 37 <span type="species:ncbi:9606">humans</span>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury
###end article-title 113
###begin article-title 114
Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury
###end article-title 114
###begin article-title 115
Generation of C5a in the absence of C3: a new complement activation pathway
###end article-title 115
###begin title 116
Figures and Tables
###end title 116
###begin p 117
###xml 32 34 32 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 42 44 42 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 0 113 0 113 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Screening of serum samples from <italic>fB</italic>-/- and <italic>fB</italic>+/+ mice for factor B protein, as shown for an exemplary Western blot</bold>
###xml 298 302 298 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 394 396 392 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 416 418 414 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 235 240 <span type="species:ncbi:10090">mouse</span>
###xml 362 368 <span type="species:ncbi:10090">murine</span>
###xml 422 426 <span type="species:ncbi:10090">mice</span>
###xml 473 478 <span type="species:ncbi:10090">mouse</span>
Screening of serum samples from fB-/- and fB+/+ mice for factor B protein, as shown for an exemplary Western blot. Samples were run out on SDS-PAGE, transferred to nitrocellulose membranes, and analyzed with a specific monoclonal anti-mouse factor B antibody and detection by chemiluminescence (ECL(R) system, Amersham). A specific 98 kDa band, corresponding to murine fB, is detectable in the fB+/+, but not in the fB-/- mice. Each lane is representative of an individual mouse. The bottom panel shows equal protein loading in the different bands by ponceau red staining.
###end p 117
###begin p 118
###xml 55 57 55 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 124 126 124 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 0 187 0 187 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Elevated C5a levels in serum of brain-injured C57BL/6 (<italic>fB</italic>+/+) mice are significantly attenuated in factor B gene-deficient (<italic>fB</italic>-/-) mice lacking a functional alternative complement pathway</bold>
###xml 222 224 222 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 232 234 232 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 266 268 266 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 337 339 337 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 355 357 355 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 367 369 367 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 460 462 458 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 470 472 468 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 476 478 474 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 492 494 490 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 498 500 496 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 502 504 500 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
###xml 410 415 <span type="species:ncbi:10090">mouse</span>
###xml 508 512 <span type="species:ncbi:10090">mice</span>
Elevated C5a levels in serum of brain-injured C57BL/6 (fB+/+) mice are significantly attenuated in factor B gene-deficient (fB-/-) mice lacking a functional alternative complement pathway. Serum samples from brain-injured fB+/+ and fB-/- mice of the C57BL/6 strain (n = 6 per group and time-point) and from normal C57BL/6 mice (control; n = 4) and normal fB-/- mice (n = 4) were analyzed by ELISA specific for mouse C5a. Data are shown as mean levels +/- SD. *P < 0.05, fB+/+ vs. control and fB+/+ vs. fB-/- mice. TBI, traumatic brain injury.
###end p 118
###begin p 119
###xml 0 122 0 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Attenuated neuronal cell death in the injured hemisphere of factor B gene-deficient mice 24 hours after closed head injury</bold>
###xml 192 194 192 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 199 209 199 209 <bold xmlns:xlink="http://www.w3.org/1999/xlink">panels A-E</bold>
###xml 239 241 239 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 246 256 246 256 <bold xmlns:xlink="http://www.w3.org/1999/xlink">panels F-J</bold>
###xml 350 360 350 360 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A, B, F, G</bold>
###xml 411 421 411 421 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D, E, I, J</bold>
###xml 513 517 513 517 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C, H</bold>
###xml 531 542 531 542 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B, E, G, J </bold>
###xml 600 610 600 610 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A, D, F, I</bold>
###xml 746 748 746 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 894 910 894 910 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A, C, D, F, H, I</bold>
###xml 919 929 919 929 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B, E, G, J</bold>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 686 690 <span type="species:ncbi:10090">mice</span>
###xml 752 756 <span type="species:ncbi:10090">mice</span>
Attenuated neuronal cell death in the injured hemisphere of factor B gene-deficient mice 24 hours after closed head injury. Coronal cryosections of the left (injured) hemisphere of wild-type (fB+/+, panels A-E) and factor B knockout mice (fB-/-, panels F-J) were analyzed by immunohistochemistry with a specific antibody to the neuronal marker NeuN (A, B, F, G) or by TUNEL-histochemistry of adjacent sections (D, E, I, J). The overall cellular morphology of the TUNEL sections is revealed by DAPI nuclear stain (C, H). The panels B, E, G, J represent a 4-fold magnification of the respective panels A, D, F, I. The evident destruction of the cortical tissue in brain-injured wild-type mice (upper panels) appears to be structurally preserved in fB-/- mice (bottom panels). The data shown here are highly reproducible in all tissue sections and animals assessed. Original magnifications: 100x (A, C, D, F, H, I), 400x (B, E, G, J).
###end p 119
###begin p 120
###xml 0 120 0 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Attenuated neuronal cell death in the injured hemisphere of factor B gene-deficient mice 7 days after closed head injury</bold>
###xml 190 192 190 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 197 207 197 207 <bold xmlns:xlink="http://www.w3.org/1999/xlink">panels A-E</bold>
###xml 237 239 237 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 244 254 244 254 <bold xmlns:xlink="http://www.w3.org/1999/xlink">panels F-J</bold>
###xml 348 358 348 358 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A, B, F, G</bold>
###xml 409 419 409 419 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D, E, I, J</bold>
###xml 511 515 511 515 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C, H</bold>
###xml 529 540 529 540 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B, E, G, J </bold>
###xml 598 608 598 608 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A, D, F, I</bold>
###xml 730 746 730 746 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A, C, D, F, H, I</bold>
###xml 755 765 755 765 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B, E, G, J</bold>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
###xml 231 235 <span type="species:ncbi:10090">mice</span>
Attenuated neuronal cell death in the injured hemisphere of factor B gene-deficient mice 7 days after closed head injury. Coronal cryosections of the left (injured) hemisphere of wild-type (fB+/+, panels A-E) and factor B knockout mice (fB-/-, panels F-J) were analyzed by immunohistochemistry with a specific antibody to the neuronal marker NeuN (A, B, F, G) or by TUNEL-histochemistry of adjacent sections (D, E, I, J). The overall cellular morphology of the TUNEL sections is revealed by DAPI nuclear stain (C, H). The panels B, E, G, J represent a 4-fold magnification of the respective panels A, D, F, I. The data shown here are highly reproducible in all tissue sections and animals assessed. Original magnifications: 100x (A, C, D, F, H, I), 400x (B, E, G, J).
###end p 120
###begin p 121
###xml 70 72 70 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 0 155 0 155 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Upregulation of Bcl-2 and downregulation of Fas receptor in brains of <italic>fB</italic>-/- mice after traumatic brain injury (TBI), as determined by Western blot analysis</bold>
###xml 255 257 255 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 265 267 265 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 487 491 484 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 511 512 506 507 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 812 814 807 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fB</italic>
###xml 896 897 891 892 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 958 960 953 955 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A </bold>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 558 563 <span type="species:ncbi:10090">mouse</span>
###xml 598 602 <span type="species:ncbi:10090">mice</span>
###xml 766 770 <span type="species:ncbi:10090">mice</span>
###xml 818 822 <span type="species:ncbi:10090">mice</span>
Upregulation of Bcl-2 and downregulation of Fas receptor in brains of fB-/- mice after traumatic brain injury (TBI), as determined by Western blot analysis. Homogenized brain tissue specimens from the injured hemispheres of sham-operated and head-injured fB+/+ and fB-/- mice were run out on SDS-PAGE, transferred to nitrocellulose membranes, and analyzed with specific monoclonal antibodies to Bcl-2, Fas, and beta-actin as internal control and detection by chemiluminescence assay (ECL(R) system, Amersham). (A) The visualized 26 kDa band corresponding to mouse Bcl-2 is enhanced in the knockout mice at 24 hours, compared to head-injured wild-type littermates. Furthermore, a downregulation in Fas receptor staining intensity is obvious in brain-injured knockout mice at all time-points assessed, compared to fB+/+ mice. The exemplary blot is representative of three independent experiments. (B) The individual band intensities of the blot shown in panel A were quantified by TINA 2.09 software (Raytest, Straubenhardt, Germany) and the data are shown as relative levels to the according beta-actin band intensity.
###end p 121

